已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Assessment of the risks associated with the use of in vivo versus in vitro potency tests for vaccines

效力 体内 体外 药理学 化学 医学 生物 生物技术 生物化学
作者
T L Schofield
出处
期刊:Biologicals [Elsevier]
卷期号:88: 101794-101794
标识
DOI:10.1016/j.biologicals.2024.101794
摘要

Animal (in vivo) potency tests have been utilized for over a century in support of vaccine development and for quality testing. This is a legacy of the best science at the time of their introduction. Advances in knowledge and technology, however, have provided opportunities to utilize more sensitive assays during development and replace legacy animal tests with in vitro alternatives. This coupled with initiatives such as replacement, reduction, and refinement (the 3-R's) and quality by design (QbD) have brought industry and regulators together in the introduction of advanced vaccine control strategies. This article examines historical and current uses of animals in vaccines technical development and control, and their replacement with in vitro alternatives from a risk point of view. An overarching risk is that a vaccine tested with an alternative potency assay fails to protect its target recipient. This can be addressed from the perspective of the assay's association with the vaccine mechanism of action, and the rules used to introduce the vaccine into the patient population (e.g., specifications). Commonly understood concepts such as analytical precision play a role in risk evaluation based on its impact on the sensitivity of a test to detect meaningful product changes caused by variations in manufacture or over a vaccine's shelf life. This should be considered when evaluating solutions such as the reduction of multi-concentration (or dilution) in vivo assays to a single concentration test. While the use of animals in vaccine development will not go away all together, the paradigm must shift from in vivo tests to in vivo models. To help ensure success, principles and practices related to introduction of in vitro alternatives require global collaboration among industry, regulators, pharmacopeias, and supporting organizations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
5秒前
kaifeiQi发布了新的文献求助10
6秒前
ding应助安安采纳,获得30
8秒前
9秒前
10秒前
11秒前
_十三发布了新的文献求助30
11秒前
AM发布了新的文献求助10
15秒前
明明发布了新的文献求助10
16秒前
贰鸟应助早睡早起身体好采纳,获得20
18秒前
今后应助polarisblue采纳,获得10
19秒前
Q123ba叭完成签到 ,获得积分10
19秒前
科研通AI2S应助AM采纳,获得10
22秒前
111完成签到,获得积分20
23秒前
zhong发布了新的文献求助10
24秒前
zhong发布了新的文献求助10
24秒前
zhong发布了新的文献求助10
25秒前
zhong发布了新的文献求助10
25秒前
快乐完成签到 ,获得积分10
27秒前
Bamboo完成签到 ,获得积分10
31秒前
mmmm应助jdjd采纳,获得10
31秒前
鬼见愁完成签到,获得积分10
32秒前
万能图书馆应助明明采纳,获得10
34秒前
35秒前
llnysl完成签到 ,获得积分10
37秒前
will完成签到 ,获得积分10
38秒前
希望天下0贩的0应助围城采纳,获得10
39秒前
小鱼发布了新的文献求助10
40秒前
41秒前
43秒前
43秒前
yfy完成签到 ,获得积分10
45秒前
缓慢的觅云完成签到,获得积分10
45秒前
活泼新儿发布了新的文献求助10
46秒前
polarisblue发布了新的文献求助10
50秒前
科研通AI2S应助迷人的Jack采纳,获得10
51秒前
初见~应助polarisblue采纳,获得10
58秒前
58秒前
777完成签到,获得积分10
59秒前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3162121
求助须知:如何正确求助?哪些是违规求助? 2813196
关于积分的说明 7899113
捐赠科研通 2472301
什么是DOI,文献DOI怎么找? 1316428
科研通“疑难数据库(出版商)”最低求助积分说明 631305
版权声明 602142